Richard T. Silver MD Myeloproliferative Neoplasms Center

Open Clinical Trials

A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Ropeginterferon alfa-2b-njft (P1101) in Adult Patients with Essential Thrombocythemia

Diseases:

Myeloproliferative Neoplasms, Essential Thrombocythemia

Location(s):

Upper East Side - Manhattan

Primary Investigator(s):

Ghaith Abu-Zeinah, MD

Study Details

(646) 962-2727

Request an Appointment Medical Records Make a Difference Email List

Richard T. Silver MD Myeloproliferative Neoplasms Center 525 East 70th St., Starr Pavillion, 3rd Floor New York, NY 10021 SilverMPNCenter@med.cornell.edu

Jump To Top